They realized that an event designed for women and gender diverse people was missing in the calendar of surf contests so they ...

Some hotels really want you to get out of your room, and they offer complimentary gear to help make it happen. For example, ...

Lundbeck has signed an agreement to acquire Longboard Pharmaceuticals for $2.6bn equity value in a move set to enhance its ...

Are you looking for the perfect board for you? We've tallied up the biggest differences between a longboard and a skateboard to help you decide. If you don't know much about skateboards or ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the former hoping to build off of its pipeline of epilepsy drug treatment.

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.

H. Lundbeck A/S will acquire Longboard Pharmaceuticals for $60 per share in a $2.6 billion deal, closing in Q4 2024. Longboard’s lead asset, bexicaserin, is under development for neurological ...

Two Southern California surfers have claimed the 2024 World Surf League’s World Longboard Championship – a second win for Dana Point native Rachael Tilly and a fourth for San Diego’s Taylor ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck's $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical ...